Active	Status	Sponsor type	Region	Phase	Filter
12 Active 8 Inactive 20 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

12 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Ranganathan, Mohini
VAST-D II, NCT05554627: VA Aripiprazole vs Esketamine for Treatment Resistant Depression	Withdrawn	4	940	US	Esketamine, Spravato (for depression), Ketanest (for anesthesia), Aripiprazole, Abilify, Aristada	VA Office of Research and Development	Depressive Disorder, Major	10/23	10/23
NAP, NCT03668041: National Adaptive Trial for PTSD Related Insomnia	Recruiting	3	774	US	Trazodone, Eszopiclone, Placebo	VA Office of Research and Development	Insomnia	02/26	02/26
NCT03708315: BXCL501 for Agitation in Schizophrenia	Recruiting	2	50	US	Dexmedetomidine Hydrochloride, Precedex, Placebos	Yale University	Schizophrenia, Schizoaffective Disorder	12/24	06/25
THC-Memory, NCT02407808: Cannabinoids, Learning, and Memory	Active, not recruiting	1	80	US	THC, Placebo	Yale University	Cannabis, Psychotic Disorders	08/18	08/25
NCT02102113: Probing the Cannabinoid System in Individuals With a Family History of Psychosis	Active, not recruiting	1	21	US	Placebo, Very Low Dose THC, delta 9-tetrahydrocannabinol, Low Dose THC	Yale University	Psychosis, Cannabis Use, THC, Marijuana, Schizophrenia	06/25	12/25
THC-Gender-I, NCT02811510: Gender Related Differences in the Acute Effects of Delta-9-Tetrahydrocannabinol in Healthy Humans: Sub-Study I	Recruiting	1	40	US	Placebo, Dronabinol, Delta-9-Tetrahydrocannabinol	Yale University	Cannabis	06/25	12/25
THC-Gender-II, NCT04704271: Gender Related Differences in the Acute Effects of Delta-9-Tetrahydrocannabinol in Healthy Humans: Sub-Study II	Recruiting	1	100	US	Inhaled THC, Delta-9-Tetrahydrocannabinol, Placebo	Yale University	Cannabis	12/24	12/24
NCT04398719: CBD-Microglia PET Study	Recruiting	1	15	US	[11C]PBR28, PET scan, Low-dose lipopolysaccharide, LPS, Intradermal Capsaicin	Yale University, National Center for Complementary and Integrative Health (NCCIH)	CBD, Healthy	09/25	09/25
CB1R in Spice, NCT03539575: CB1R in Synthetic Psychoactive Cannabinoids	Active, not recruiting	N/A	15	US	[11-C]OMAR	Yale University, National Institutes of Health (NIH), National Institute on Drug Abuse (NIDA)	Drug Dependence	12/24	12/24
AID-ME, NCT04655924: Artificial Intelligence in Depression - Medication Enhancement	Completed	N/A	94	Canada, US	Clinical Decision Support System	Aifred Health, McGill University	Depression	12/23	12/23
Forselius-Bielen, Kimberlee
NCT05465538: SV2A in Older Adults	Recruiting	1/2	24	US	[11C]UCB-J PET	Yale University, National Institute on Drug Abuse (NIDA)	Cannabis Use	09/25	09/25
NCT05105542: M1 Schizophrenia PET Study	Completed	1	18	US	11C-EMO - A Novel PET Radiotracer for Muscarinic M1 Receptor, PET Scan	Yale University, National Institute of Mental Health (NIMH)	Schizophrenia, Schizoaffective Disorder, Healthy	10/23	10/23